Mohammed Al Kanan: Early Identification of VTE Risk in Lung Cancer Patients
Mohammed Al Kanan, Director of Research and Studies at Ministry of Health Saudi Arabia, shared a post on LinkedIn about a recent article by Rong Deng et al. published in Frontiers in Molecular Biosciences, adding:
“Pleased to have contributed as a peer reviewer for a newly published original research article in Frontiers in Molecular Biosciences:
Construction and verification of a nomogram to predict the probability of venous thromboembolism in lung cancer patients.
This study tackles an important challenge in oncology: early identification of lung cancer patients at increased risk of venous thromboembolism (VTE) to support more individualized thromboprophylaxis and clinical decision-making.
Among 676 patients with lung cancer, the investigators developed a lung cancer–specific predictive nomogram incorporating clinically relevant factors such as acute infection, prolonged bed rest, D-dimer, adenocarcinoma, CEA, and COMPASS-CAT score.
What makes the findings particularly interesting is the model’s performance: AUC 0.894, outperforming several conventional VTE risk assessment tools, with favorable discrimination and calibration.
The work represents another step toward moving from generalized risk scores to more disease-specific and individualized prediction models—while prospective validation remains essential before widespread clinical implementation.
Grateful for the opportunity to contribute to the peer-review process and advancement of clinically relevant research.”
Title: Construction and verification of a nomogram to predict the probability of venous thromboembolism in lung cancer patients
Authors: Rong Deng, Jing Wu, Fei Tang, Yan Li, Qin Zhong, Ying Tong, Tingting Ni, Yu Zhang
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 22, 2026, 17:10Matthew Hazell: Optimizing the Use of Rare Red Blood Cell Units
-
Oct 22, 2026, 17:03Smita Patil: New Insights Into Platelet Alpha-Granule Secretion
-
Oct 22, 2026, 16:48Ahmed Alotaibi: Rare Rh Phenotype and Severe Fetal Anaemia
-
Oct 22, 2026, 16:36Alissa Odum: Every Blood Type Matters Every Donation Saves Lives
-
Oct 22, 2026, 16:33Mehul Malhotra: Targeted Therapies and Clinical Advances Transform the wAIHA Treatment Landscape
-
Oct 22, 2026, 16:13William Wallace: The Hidden Neurological Impact of Vitamin B12 Deficiency
-
Oct 22, 2026, 16:06Akram Farhadi: Anemia and Low Hemoglobin Associated With Higher Risk of Osteosarcopenia in Older Adults
-
Oct 22, 2026, 15:49Javed Iqbal: NUMC Pulmonary and Critical Care Team Showcases Research at CHEST 2026
-
Oct 22, 2026, 15:37Alina Mitina: Key Concerns Surrounding DVT and Pulmonary Embolism